by Andrew Bogue | Industry Expertise, Life Sciences
Venture capital (VC) investment in life sciences is at an all-time high. In the face of the COVID-19 pandemic, the biopharma industry attracted new interest after a series of highly visible accomplishments. Breakthroughs in vaccines certainly gave investors a glimpse...
